chenodeoxycholic acid has been researched along with endothelin-1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alber, S; He, F; Jiang, Y; Kuruba, R; Li, J; Li, S; Ma, Z; Mu, Y; Pitt, B; Stevens, T; Watkins, S; Wilson, A; Xie, W | 1 |
| Chi, X; Lan, X; Li, C; Li, J; Weng, X | 1 |
2 other study(ies) available for chenodeoxycholic acid and endothelin-1
| Article | Year |
|---|---|
Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells.
Topics: Animals; Cells, Cultured; Chenodeoxycholic Acid; DNA-Binding Proteins; Down-Regulation; Endothelial Cells; Endothelin-1; Gene Expression Regulation; Humans; Promoter Regions, Genetic; Pulmonary Artery; Rabbits; Rats; Receptors, Cytoplasmic and Nuclear; Response Elements; Transcription Factor AP-1; Transcription Factors; Transcriptional Activation | 2006 |
Farnesoid X receptor agonist CDCA reduces blood pressure and regulates vascular tone in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Chenodeoxycholic Acid; Disease Models, Animal; Endothelin-1; Hypertension; Mesenteric Arteries; NF-kappa B; Nitric Oxide Synthase; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Vascular Cell Adhesion Molecule-1; Vasoconstriction; Vasodilation | 2015 |